Why Milestone Pharmaceuticals stock wilted on Wednesday
The biotech fell well short of analyst projections in the first quarter.
The biotech fell well short of analyst projections in the first quarter.
MIST
1.0402.80%
Login to unlock72characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.